AIMS: To evaluate the effects of cardiac resynchronization therapy (CRT) on long-term survival of patients without baseline left ventricular (LV) mechanical dyssynchrony. METHODS AND RESULTS: A total of 290 heart failure patients (age 67 ± 10 years, 77% males) without significant baseline LV dyssynchrony (<60 ms as assessed with tissue Doppler imaging) were treated with CRT. Patients were divided according to the median LV dyssynchrony measured after 48 h of CRT into two groups. All-cause mortality was compared between the subgroups. In addition, the all-cause mortality rates of these subgroups were compared with the all-cause mortality of 290 heart failure patients treated with CRT who showed significant LV dyssynchrony (≥60 ms) at baseline. In the group of patients without significant LV dyssynchrony, median LV dyssynchrony increased from 22 ms (inter-quartile range 16-34 ms) at baseline to 40 ms (24-56 ms) 48 h after CRT. The cumulative mortality rates at 1-, 2-, and 3-year follow-up of patients with LV dyssynchrony ≥40 ms 48 h after CRT implantation were significantly higher when compared with patients with LV dyssynchrony <40 ms (10, 17, and 23 vs. 3, 8, and 10%, respectively; log-rank P< 0.001). Finally, the cumulative mortality rates at 1-, 2-, and 3-year follow-up of patients with baseline LV dyssynchrony were 3, 8, and 11%, respectively (log-rank P= 0.375 vs. patients with LV dyssynchrony <40 ms). Induction of LV dyssynchrony after CRT was an independent predictor of mortality (hazard ratio: 1.247; P= 0.009). CONCLUSION: In patients without significant LV dyssynchrony, the induction of LV dyssynchrony after CRT may be related to a less favourable long-term outcome.
AIMS: To evaluate the effects of cardiac resynchronization therapy (CRT) on long-term survival of patients without baseline left ventricular (LV) mechanical dyssynchrony. METHODS AND RESULTS: A total of 290 heart failurepatients (age 67 ± 10 years, 77% males) without significant baseline LV dyssynchrony (<60 ms as assessed with tissue Doppler imaging) were treated with CRT. Patients were divided according to the median LV dyssynchrony measured after 48 h of CRT into two groups. All-cause mortality was compared between the subgroups. In addition, the all-cause mortality rates of these subgroups were compared with the all-cause mortality of 290 heart failurepatients treated with CRT who showed significant LV dyssynchrony (≥60 ms) at baseline. In the group of patients without significant LV dyssynchrony, median LV dyssynchrony increased from 22 ms (inter-quartile range 16-34 ms) at baseline to 40 ms (24-56 ms) 48 h after CRT. The cumulative mortality rates at 1-, 2-, and 3-year follow-up of patients with LV dyssynchrony ≥40 ms 48 h after CRT implantation were significantly higher when compared with patients with LV dyssynchrony <40 ms (10, 17, and 23 vs. 3, 8, and 10%, respectively; log-rank P< 0.001). Finally, the cumulative mortality rates at 1-, 2-, and 3-year follow-up of patients with baseline LV dyssynchrony were 3, 8, and 11%, respectively (log-rank P= 0.375 vs. patients with LV dyssynchrony <40 ms). Induction of LV dyssynchrony after CRT was an independent predictor of mortality (hazard ratio: 1.247; P= 0.009). CONCLUSION: In patients without significant LV dyssynchrony, the induction of LV dyssynchrony after CRT may be related to a less favourable long-term outcome.
Authors: Matteo Bertini; Nina Ajmone Marsan; Victoria Delgado; Rutger J van Bommel; Gaetano Nucifora; C Jan Willem Borleffs; Giuseppe Boriani; Mauro Biffi; Eduard R Holman; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax Journal: J Am Coll Cardiol Date: 2009-09-29 Impact factor: 24.094
Authors: Rutger J Van Bommel; Claudia Ypenburg; C Jan Willem Borleffs; Victoria Delgado; Nina Ajmone Marsan; Matteo Bertini; Eduard R Holman; Martin J Schalij; Jeroen J Bax Journal: Am J Cardiol Date: 2010-02-20 Impact factor: 2.778
Authors: Rutger J van Bommel; Carel Jan Willem Borleffs; Claudia Ypenburg; Nina Ajmone Marsan; Victoria Delgado; Matteo Bertini; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax Journal: Eur Heart J Date: 2010-08-07 Impact factor: 29.983
Authors: Rutger J van Bommel; Jeroen J Bax; William T Abraham; Eugene S Chung; Luis A Pires; Luigi Tavazzi; Peter J Zimetbaum; Bart Gerritse; Nina Kristiansen; Stefano Ghio Journal: Eur Heart J Date: 2009-08-30 Impact factor: 29.983
Authors: Michael O Sweeney; Rutger J van Bommel; Martin J Schalij; C Jan Willem Borleffs; Anne S Hellkamp; Jeroen J Bax Journal: Circulation Date: 2010-01-25 Impact factor: 29.690
Authors: Rutger J van Bommel; Hidekazu Tanaka; Victoria Delgado; Matteo Bertini; Carel Jan Willem Borleffs; Nina Ajmone Marsan; Johannes Holzmeister; Frank Ruschitzka; Martin J Schalij; Jeroen J Bax; John Gorcsan Journal: Eur Heart J Date: 2010-09-23 Impact factor: 29.983
Authors: Gregory R Hartlage; Jonathan D Suever; Stephanie Clement-Guinaudeau; Patrick T Strickland; Nima Ghasemzadeh; R Patrick Magrath; Ankit Parikh; Stamatios Lerakis; Michael H Hoskins; Angel R Leon; Michael S Lloyd; John N Oshinski Journal: J Cardiovasc Magn Reson Date: 2015-07-14 Impact factor: 5.364